FDA Inspection 1255313 — Ranjitkumar Rathwa, M.B.B.S.
The FDA completed an inspection of Ranjitkumar Rathwa, M.B.B.S. on October 11, 2024 in Ahmedabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 11, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ahmedabad (India)
Additional Details
Clinical BA/BE